Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHAT Phathom Pharmaceuticals

盘后交易 06-25 18:17:05 EDT

10.34

-0.27

-2.54%

盘后10.34

+0.000.00%

16:10 EDT

最高10.78	最低10.02	成交量108.24万
今开10.60	昨收10.61	日振幅7.16%
总市值8.21亿	流通市值5.95亿	总股本7,943万
成交额1,110万	换手率1.88%	流通股本5,757万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":10.34,"timestamp":1782417600000,"preClose":10.61,"halted":0,"volume":1082356,"hourTrading":{"tag":"盘后","latestPrice":10.34,"preClose":10.34,"latestTime":"16:10 EDT","volume":24549,"amount":253836.66,"timestamp":1782418205594,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025447690857681393,"floatShares":57566899,"shares":79430117,"eps":-2.085468,"marketStatus":"盘后交易","change":-0.27,"latestTime":"06-25 18:17:05 EDT","open":10.6,"high":10.78,"low":10.02,"amount":11102613,"amplitude":0.071631,"askPrice":11.34,"askSize":100,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.085468,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782432000000},"marketStatusCode":4,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":10.61,"preHourTrading":{"tag":"盘前","latestPrice":10.61,"preClose":10.61,"latestTime":"09:28 EDT","volume":5903,"amount":63135.719493000004,"timestamp":1782394081048,"change":0,"changeRate":0,"amplitude":0.029218},"postHourTrading":{"tag":"盘后","latestPrice":10.34,"preClose":10.34,"latestTime":"16:10 EDT","volume":24549,"amount":253836.66,"timestamp":1782418205594,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.307713,"impliedVol":0.5578,"impliedVolPercentile":0.1076},"requestUrl":"/m/hq/s/PHAT/wiki","defaultTab":"wiki","newsList":[{"id":"1131031397","title":"Phathom Pharmaceuticals 提前完成 Voquezna®（Vonoprazan）治疗嗜酸性粒细胞性食管炎（EoE）的二期研究患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1131031397","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131031397?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:00","pubTimestamp":1782216015,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals 已提前完成其针对嗜酸性粒细胞性食管炎（EoE）的二期临床试验 Phalcon-Eoe-201 的患者招募工作。该试验旨在评估其药物 Voquezna®（Vonoprazan）的疗效与安全性。这一进展标志着公司在推进该创新疗法的临床开发道路上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192918450","title":"Phathom制药公司维持2026财年业绩指引，预计自第三季度起实现运营盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1192918450","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192918450?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:05","pubTimestamp":1777547118,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals Inc（简称：Phathom制药）近日宣布，公司决定维持其2026财年的全年业绩指引不变。与此同时，该公司预计将从2026年第三季度开始实现运营层面的盈利。\n这一预期标志着公司发展的重要转折点，表明其核心业务已具备持续产生正向现金流的能力。管理层对实现这一里程碑充满信心，反映出公司战略执行的有效性与市场对其产品需求的积极前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145592037","title":"Phathom Pharmaceuticals将于2026年4月30日公布第一季度财报并举行业务说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1145592037","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145592037?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:00","pubTimestamp":1776686438,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals宣布，公司计划于2026年4月30日（星期四）正式发布2026财年第一季度财务业绩报告。此次公告将同步进行业务进展说明，向投资者全面展示公司最新发展动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603572114","title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603572114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603572114?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229118,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报14.26美元/股，成交量25.3004万股，换手率0.32%，振幅5.00%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Day One Biopharmaceuticals, Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为539.06%、111.98%、48.43%，振幅较大的相关个股有Pyxis Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs, Inc.，振幅分别为26.42%、25.56%、24.64%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224518a7120e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224518a7120e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100611774","title":"Phathom Pharmaceuticals公布1.3亿美元普通股及预先注资认股权证公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1100611774","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100611774?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:34","pubTimestamp":1767843258,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals今日正式宣布，已完成其普通股及预先注资认股权证公开发行的定价工作。此次发行规模总计高达1.3亿美元，标志着公司在资本市场的又一重要融资举措。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518205329","title":"高盛：维持Phathom Pharmaceuticals(PHAT.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205329?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628482,"startTime":"0","endTime":"0","summary":"高盛：维持Phathom Pharmaceuticals(PHAT.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11014148641581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227203","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速下跌5.24%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227203?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613580,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Phathom Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.24%。截至发稿，该股报4.80美元/股，成交量7.1426万股，换手率0.10%，振幅4.20%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2045.40%、403.94%、59.60%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为99.91%、99.13%、98.72%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518289792","title":"Phathom Pharmaceuticals, Inc.2024财年实现净利润-3.34亿美元，同比减少65.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289792?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536072,"startTime":"0","endTime":"0","summary":"3月10日，Phathom Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-3.34亿美元，同比减少65.35%；其中营业收入为55.25百万美元，同比增加8001.17%，每股基本收益为-5.29美元。机构评级：截至2025年3月10日，当前有8家机构对Phathom Pharmaceuticals, Inc.目标价做出预测，其中目标均价为21.62美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517152379","title":"Phathom Pharmaceuticals(PHAT.US)：2024年Q4财报实现营收2966.4万美元，前值为68.2万美元，预期值为2565万美元；每股收益为-0.79美元，前值为-0.80美元，预期值为-1.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517152379","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517152379?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:12","pubTimestamp":1741266750,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals(PHAT.US)：2024年Q4财报实现营收2966.4万美元，前值为68.2万美元，预期值为2565万美元；每股收益为-0.79美元，前值为-0.80美元，预期值为-1.08美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06211248574105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118505333","title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27)，销售额$29.66百万优于$24.91百万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1118505333","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118505333?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:10","pubTimestamp":1741266636,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals报告本季度每股亏损$，超过分析师共识预期的$，提高了37.8%。这比去年同期每股亏损$增加了1.25%。这比去年同期销售额$682,000增长了4,250%。以上内容来自Benzinga Earnings专栏，原文如下：$Phathom Pharmaceuticals$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 37.8 percent. This is a 1.25 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent.  This is a","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27)，销售额$29.66百万优于$24.91百万预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517284609","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517284609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517284609?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:28","pubTimestamp":1741199304,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时28分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为950.81%、305.93%、302.22%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022824a2610899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022824a2610899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517985659","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.37%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985659?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:15","pubTimestamp":1741119353,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时15分，Phathom Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.37%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hoth Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1326.08%、1255.21%、1219.34%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041553989bfb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041553989bfb32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514937556","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514937556?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:56","pubTimestamp":1740754592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.21%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Enveric Biosciences, Inc.、Puma Biotechnology Inc、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为626.68%、367.39%、303.39%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、35.13%、29.25%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822563298968002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822563298968002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514866851","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.38%报5.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866851?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.38%。截至发稿，该股报5.88美元/股，成交量5.9977万股，换手率0.09%，振幅2.06%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2798.65%、116.09%、90.30%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为29.66%、16.86%、14.35%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262232119893aae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262232119893aae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514155390","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514155390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514155390?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:07","pubTimestamp":1740496063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时07分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.24%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1028.28%、777.69%、580.87%，振幅较大的相关个股有Organovo Holdings, Inc.、Gri Bio, Inc.、Adial Pharmaceuticals, Inc，振幅分别为121.95%、56.51%、47.10%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230743962ffb03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230743962ffb03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703852","title":"Phathom Pharmaceuticals, Inc.盘中异动 急速下跌5.03%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703852?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:16","pubTimestamp":1740428178,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时16分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.03%。截至发稿，该股报5.39美元/股，成交量79.7323万股，换手率1.17%，振幅5.47%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为326.72%、141.67%、40.73%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041619962edcdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041619962edcdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511520426","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511520426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511520426?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:49","pubTimestamp":1739465351,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时49分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。截至发稿，该股报5.76美元/股，成交量12.9359万股，换手率0.19%，振幅6.02%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Enanta Pharmaceuticals, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2828.37%、1194.06%、167.30%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214004912a244c83b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214004912a244c83b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510920867","title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅下挫5.08%报5.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510920867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510920867?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:35","pubTimestamp":1739205336,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时35分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.08%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2828.04%、1570.44%、1105.50%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003536961e181e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003536961e181e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509747305","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.08%报5.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509747305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509747305?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:59","pubTimestamp":1738940348,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时59分，Phathom Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.08%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为3150.25%、81.27%、67.95%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、45.02%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225909987db261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225909987db261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509728298","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509728298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509728298?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:40","pubTimestamp":1738766444,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时40分，Phathom Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.12%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.64%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3302.58%、896.60%、640.25%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Oragenics Inc.、Pasithea Therapeutics Corp.，振幅分别为54.05%、42.20%、30.29%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205224045a23a7d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205224045a23a7d36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":-0.0355},{"period":"1month","weight":-0.0635},{"period":"3month","weight":-0.0167},{"period":"6month","weight":-0.3958},{"period":"1year","weight":0.0871},{"period":"ytd","weight":-0.3605}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0166},{"period":"3month","weight":0.1366},{"period":"6month","weight":0.0622},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0753}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phathom Pharmaceuticals, Inc.于2018年1月9日根据特拉华州法律注册成立。该公司是一家生物制药公司，专注于开发和商业化治疗胃肠道疾病或GI疾病的新疗法。公司已获批的产品包括 VOQUEZNA、VOQUEZNA DUAL PAK 和 VOQUEZNA TRIPLE PAK，它们均含有伏诺拉生（vonoprazan），一种口服小分子钾离子竞争性酸阻滞剂（PCAB）。PCAB 是一类新型分子，能够抑制胃酸分泌。VOQUEZNA 是目前美国唯一获准上市销售的 PCAB。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.0658},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.119249},{"month":4,"riseRate":0.571429,"avgChangeRate":0.046876},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.041373},{"month":6,"riseRate":0.714286,"avgChangeRate":0.226716},{"month":7,"riseRate":0.666667,"avgChangeRate":0.025067},{"month":8,"riseRate":0.666667,"avgChangeRate":0.15186},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003613},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040055},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.100392},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}